JB CHEMICALS & PHARMACEUTICALS
|
JB CHEMICALS & PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹16 Cr |
Equity - Authorised | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr |
Equity - Issued | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹16 Cr |
Equity Paid Up | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹16 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | ₹122 Cr | ₹63 Cr | - | - | - |
Total Reserves | ₹2,343 Cr | ₹2,056 Cr | ₹1,794 Cr | ₹1,420 Cr | ₹1,464 Cr |
Securities Premium | ₹70 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr |
Capital Reserves | ₹-0.04 Cr | ₹0.68 Cr | ₹0.68 Cr | ₹0.68 Cr | ₹0.68 Cr |
Profit & Loss Account Balance | ₹2,125 Cr | ₹1,843 Cr | ₹1,585 Cr | ₹1,223 Cr | ₹1,102 Cr |
General Reserves | ₹130 Cr | ₹130 Cr | ₹130 Cr | ₹130 Cr | ₹291 Cr |
Other Reserves | ₹18 Cr | ₹31 Cr | ₹28 Cr | ₹15 Cr | ₹19 Cr |
Reserve excluding Revaluation Reserve | ₹2,343 Cr | ₹2,056 Cr | ₹1,794 Cr | ₹1,420 Cr | ₹1,464 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹2,480 Cr | ₹2,134 Cr | ₹1,810 Cr | ₹1,435 Cr | ₹1,480 Cr |
Minority Interest | - | ₹4.49 Cr | ₹3.71 Cr | ₹2.50 Cr | ₹2.80 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹383 Cr | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹520 Cr | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-137 Cr | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹96 Cr | ₹41 Cr | ₹50 Cr | ₹48 Cr | ₹57 Cr |
Deferred Tax Assets | ₹18 Cr | ₹19 Cr | ₹22 Cr | ₹16 Cr | ₹20 Cr |
Deferred Tax Liability | ₹114 Cr | ₹60 Cr | ₹72 Cr | ₹64 Cr | ₹77 Cr |
Other Long Term Liabilities | ₹18 Cr | ₹24 Cr | ₹10 Cr | ₹7.20 Cr | ₹2.20 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹495 Cr | ₹410 Cr | ₹13 Cr | ₹7.39 Cr | ₹5.73 Cr |
Total Non-Current Liabilities | ₹992 Cr | ₹475 Cr | ₹72 Cr | ₹63 Cr | ₹65 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹239 Cr | ₹224 Cr | ₹187 Cr | ₹168 Cr | ₹117 Cr |
Sundry Creditors | ₹239 Cr | ₹224 Cr | ₹187 Cr | ₹168 Cr | ₹117 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹240 Cr | ₹81 Cr | ₹90 Cr | ₹103 Cr | ₹93 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹12 Cr | ₹4.32 Cr | ₹4.23 Cr | ₹21 Cr | ₹13 Cr |
Interest Accrued But Not Due | ₹0.03 Cr | ₹0.01 Cr | ₹0.00 Cr | ₹0.02 Cr | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹228 Cr | ₹77 Cr | ₹86 Cr | ₹81 Cr | ₹80 Cr |
Short Term Borrowings | ₹28 Cr | ₹26 Cr | ₹33 Cr | ₹29 Cr | ₹26 Cr |
Secured ST Loans repayable on Demands | ₹28 Cr | ₹26 Cr | ₹33 Cr | ₹29 Cr | ₹23 Cr |
Working Capital Loans- Sec | ₹28 Cr | ₹26 Cr | ₹33 Cr | ₹29 Cr | ₹23 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-28 Cr | ₹-26 Cr | ₹-33 Cr | ₹-29 Cr | ₹-21 Cr |
Short Term Provisions | ₹119 Cr | ₹123 Cr | ₹377 Cr | ₹216 Cr | ₹545 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹76 Cr | ₹78 Cr | ₹349 Cr | ₹209 Cr | ₹541 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹43 Cr | ₹46 Cr | ₹28 Cr | ₹7.11 Cr | ₹3.98 Cr |
Total Current Liabilities | ₹626 Cr | ₹455 Cr | ₹687 Cr | ₹516 Cr | ₹782 Cr |
Total Liabilities | ₹4,098 Cr | ₹3,069 Cr | ₹2,572 Cr | ₹2,017 Cr | ₹2,329 Cr |
ASSETS | |||||
Gross Block | ₹2,608 Cr | ₹1,876 Cr | ₹1,183 Cr | ₹1,177 Cr | ₹1,085 Cr |
Less: Accumulated Depreciation | ₹707 Cr | ₹599 Cr | ₹549 Cr | ₹526 Cr | ₹464 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹1,901 Cr | ₹1,277 Cr | ₹634 Cr | ₹651 Cr | ₹621 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹44 Cr | ₹14 Cr | ₹26 Cr | ₹16 Cr | ₹15 Cr |
Non Current Investments | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹69 Cr | ₹96 Cr |
Long Term Investment | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹69 Cr | ₹96 Cr |
Quoted | - | - | - | ₹57 Cr | ₹84 Cr |
Unquoted | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹12 Cr |
Long Term Loans & Advances | ₹514 Cr | ₹435 Cr | ₹5.62 Cr | ₹3.59 Cr | ₹8.31 Cr |
Other Non Current Assets | ₹15 Cr | ₹1.04 Cr | ₹0.82 Cr | ₹0.36 Cr | ₹0.59 Cr |
Total Non-Current Assets | ₹2,499 Cr | ₹1,745 Cr | ₹679 Cr | ₹741 Cr | ₹741 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹192 Cr | - | ₹665 Cr | ₹334 Cr | ₹361 Cr |
Quoted | ₹192 Cr | - | ₹665 Cr | ₹334 Cr | ₹361 Cr |
Unquoted | - | - | - | - | - |
Inventories | ₹430 Cr | ₹410 Cr | ₹347 Cr | ₹275 Cr | ₹244 Cr |
Raw Materials | ₹166 Cr | ₹152 Cr | ₹129 Cr | ₹95 Cr | ₹77 Cr |
Work-in Progress | ₹36 Cr | ₹19 Cr | ₹24 Cr | ₹22 Cr | ₹19 Cr |
Finished Goods | ₹123 Cr | ₹132 Cr | ₹138 Cr | ₹90 Cr | ₹95 Cr |
Packing Materials | ₹46 Cr | ₹50 Cr | ₹29 Cr | ₹31 Cr | ₹23 Cr |
Stores Ā and Spare | ₹0.79 Cr | ₹0.78 Cr | ₹0.41 Cr | ₹0.43 Cr | ₹0.33 Cr |
Other Inventory | ₹58 Cr | ₹56 Cr | ₹27 Cr | ₹36 Cr | ₹30 Cr |
Sundry Debtors | ₹576 Cr | ₹556 Cr | ₹389 Cr | ₹345 Cr | ₹308 Cr |
Debtors more than Six months | ₹23 Cr | ₹36 Cr | ₹19 Cr | ₹0.27 Cr | ₹0.20 Cr |
Debtors Others | ₹558 Cr | ₹524 Cr | ₹375 Cr | ₹345 Cr | ₹308 Cr |
Cash and Bank | ₹79 Cr | ₹59 Cr | ₹31 Cr | ₹31 Cr | ₹37 Cr |
Cash in hand | ₹0.04 Cr | ₹0.09 Cr | ₹0.13 Cr | ₹0.23 Cr | ₹0.20 Cr |
Balances at Bank | ₹79 Cr | ₹44 Cr | ₹28 Cr | ₹31 Cr | ₹37 Cr |
Other cash and bank balances | - | ₹15 Cr | ₹2.43 Cr | ₹0.10 Cr | ₹0.01 Cr |
Other Current Assets | ₹45 Cr | ₹57 Cr | ₹46 Cr | ₹19 Cr | ₹33 Cr |
Interest accrued on Investments | ₹0.39 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.07 Cr | ₹0.05 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹17 Cr | ₹12 Cr | ₹12 Cr | ₹7.98 Cr | ₹7.83 Cr |
Other current_assets | ₹28 Cr | ₹45 Cr | ₹34 Cr | ₹11 Cr | ₹25 Cr |
Short Term Loans and Advances | ₹277 Cr | ₹243 Cr | ₹416 Cr | ₹272 Cr | ₹606 Cr |
Advances recoverable in cash or in kind | ₹14 Cr | ₹31 Cr | ₹3.71 Cr | ₹14 Cr | ₹14 Cr |
Advance income tax and TDS | ₹71 Cr | ₹71 Cr | ₹358 Cr | ₹219 Cr | ₹545 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹192 Cr | ₹140 Cr | ₹54 Cr | ₹40 Cr | ₹47 Cr |
Total Current Assets | ₹1,599 Cr | ₹1,325 Cr | ₹1,894 Cr | ₹1,276 Cr | ₹1,589 Cr |
Net Current Assets (Including Current Investments) | ₹974 Cr | ₹869 Cr | ₹1,207 Cr | ₹760 Cr | ₹807 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹4,098 Cr | ₹3,069 Cr | ₹2,572 Cr | ₹2,017 Cr | ₹2,329 Cr |
Contingent Liabilities | ₹105 Cr | ₹49 Cr | ₹54 Cr | ₹74 Cr | ₹48 Cr |
Total Debt | ₹548 Cr | ₹26 Cr | ₹33 Cr | ₹29 Cr | ₹26 Cr |
Book Value | 304.83 | 268.04 | 234.17 | 185.75 | 184.47 |
Adjusted Book Value | 304.83 | 268.04 | 234.17 | 185.75 | 184.47 |
Compare Balance Sheet of peers of JB CHEMICALS & PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JB CHEMICALS & PHARMACEUTICALS | ₹27,601.5 Cr | 1.9% | -1.9% | 64.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
JB CHEMICALS & PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JB CHEMICALS & PHARMACEUTICALS | 1.9% |
-1.9% |
64.7% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses